Patients (n = 13) | Controls (n = 15) | p | |
Serum aCl IgG | 7.6 ± 3.9 | 9.5 ± 7.2 | 0.23 |
Serum aCl IgM | 6.0 ± 3.7 | 6.7 ± 4.2 | 0.78 |
Serum Antiβ2-GP1 | 18.0 ± 27.8 | 1.8 ± 0.5 | 0.01 |
AF aCl IgG | 12.4 ± 9.1 | 9.8 ± 5.5 | 0.48 |
AF aCl IgM | 3.5 ± 9.5 | 2.3 ± 3.3 | 0.23 |
AF Antiβ2-GP1 | 20.9 ± 22.0 | 4.6 ±2.9 | 0.005 |